Twin anemia-polycythemia sequence

Last updated
Twin anemia-polycythemia sequence
Other namesTAPS
TAPS legs twins.jpg
Photo of twins legs with twin anemia-polycythemia sequence color difference
Specialty Obstetrics

Twin anemia-polycythemia sequence (TAPS) is a chronic type of unbalanced fetal transfusion in monochorionic twins that results in polycythemia in the TAPS recipient and anemia in the TAPS donor due to tiny placental anastomoses. [1] Post-laser TAPS and spontaneous TAPS are the two forms of TAPS. Unlike twin-to-twin transfusion syndrome, which arises when twin oligohydramnios polyhydramnios sequence (TOPS) is present, TAPS develops in its absence. [2]

Contents

Signs and symptoms

A pale, anemic donor and a plethoric, polycythemic recipient make up the traditional clinical picture of TAPS. [3]

In 29% of spontaneous TAPS twins and 23% of post-laser TAPS twins, severe fetal growth restriction is present. [4] [5]

Causes

The cause of TAPS is slow and persistent unbalanced feto-fetal transfusion through tiny placental anastomoses, which progressively results in highly discordant hemoglobin levels. This causes the recipient twin to become polycythemic and the donor twin to become anemic. [1]

Mechanism

There are very few, tiny arteriovenous vascular anastomoses present in TAPS placentas. This distinct angiography is the foundation of the pathogenesis of TAPS. A slow transfusion of blood from the donor to the recipient is made possible by the few tiny anastomoses, which eventually cause very disparate hemoglobin levels. It's unclear if hormonal dysfunction may also contribute to the onset of TAPS. [6]

Diagnosis

Doppler ultrasound abnormalities demonstrating an increased peak systolic velocity in the middle cerebral arteries (MCAPSV) in the donor twin and a decreased MCA-PSV in the recipient twin can be used to make an antenatal diagnosis of TAPS. The presence of polycythemia in the recipient and (chronic) anemia in the donor, along with characteristic placental angioarchitecture as determined by injection with colored dye, are the basis for the postnatal diagnosis of TAPS. [6]

Classification

Antenatal twin anemia-polycythemia sequence classification. [6]
Antenatal stageResults of a Doppler ultrasound scan
Stage 1MCA-PSV donor >1.5 MoM and MCA-PSV recipient <1.0 MoM, without other signs of fetal compromise
Stage 2MCA-PSV donor >1.7 MoM and MCA-PSV recipient <0.8 MoM, without other signs of fetal compromise
Stage 3As stage 1 or 2, with cardiac compromise of donor, defined as critically abnormal flow. [note 1]
Stage 4Hydrops of donor.
Stage 5Intrauterine demise of one or both fetuses preceded by TAPS
Postnatal TAPS classification. [6]
Postnatal stageIntertwin hemoglobin difference, g/dl
Stage 1>8.0
Stage 2>11.0
Stage 3>14.0
Stage 4>17.0
Stage 5>20.0

Prevention

The rate of residual anastomoses can be decreased to prevent postlaser TAPS. The "Solomon technique," an alternate method of laser surgery, may help lower the possibility of omitting a tiny anastomosis during the procedure. [6]

Treatment

Weekly ultrasound monitoring, which includes a full staging Doppler examination with the MCA-PSV, is part of the expectant management protocol. The recent onset of ultrasound abnormalities may require an increase in the surveillance frequency. When TAPS patients present in the first or early second trimester, this approach is preferred because many of these patients may resolve or remain clinically stable. Expectant care can be continued with the aim of achieving a late preterm delivery in stable cases that do not advance past stage 2. It is necessary to take into account alternate management options if TAPS is accelerating. [7]

Treatments that are temporary include intrauterine blood transfusion of the anemic donor twin or exchange transfusions, which remove blood from the recipient twin and then transfusion of the donor. [8]

Treating TAPS with fetal laser coagulation of vascular anastomoses is the only potentially effective modality. [9]

Outlook

In the TAPS Registry cohort, 11% of post-laser TAPS twins and 5% of spontaneous TAPS twins experienced spontaneous fetal death. [5] [4]

Epidemiology

Postlaser TAPS can occur in 2–13% of cases, depending on the definitions and criteria applied. [10] [11] The range of incidence for spontaneous TAPS is 3–5%. [6]

See also

Notes

  1. Critically abnormal Doppler is defined as pulsatile flow in the umbilical vein, absent or reversed end-diastolic flow in the umbilical artery, increased pulsatility index, or reversed flow in the ductus veinosus. [6]

Related Research Articles

<span class="mw-page-title-main">Vanishing twin</span> Medical condition

A vanishing twin, also known as twin resorption, is a fetus in a multigestation pregnancy that dies in utero and is then partially or completely reabsorbed. In some instances, the dead twin is compressed into a flattened, parchment-like state known as fetus papyraceus.

<span class="mw-page-title-main">Twin-to-twin transfusion syndrome</span> Medical condition

Twin-to-twin transfusion syndrome (TTTS), also known as feto-fetal transfusion syndrome (FFTS), twin oligohydramnios-polyhydramnios sequence (TOPS) and stuck twin syndrome, is a complication of monochorionic multiple pregnancies in which there is disproportionate blood supply between the fetuses. This leads to unequal levels of amniotic fluid between each fetus and usually leads to death of the undersupplied twin and, without treatment, usually death or a range of birth defects or disabilities for a surviving twin, such as underdeveloped, damaged or missing limbs, digits or organs, especially cerebral palsy.

<span class="mw-page-title-main">Hemolytic disease of the newborn</span> Fetal and neonatal alloimmune blood condition

Hemolytic disease of the newborn, also known as hemolytic disease of the fetus and newborn, HDN, HDFN, or erythroblastosis fetalis, is an alloimmune condition that develops in a fetus at or around birth, when the IgG molecules produced by the mother pass through the placenta. Among these antibodies are some which attack antigens on the red blood cells in the fetal circulation, breaking down and destroying the cells. The fetus can develop reticulocytosis and anemia. The intensity of this fetal disease ranges from mild to very severe, and fetal death from heart failure can occur. When the disease is moderate or severe, many erythroblasts are present in the fetal blood, earning these forms of the disease the name erythroblastosis fetalis.

<span class="mw-page-title-main">Hydrops fetalis</span> Human disease of fetuses

Hydrops fetalis or hydrops foetalis is a condition in the fetus characterized by an accumulation of fluid, or edema, in at least two fetal compartments. By comparison, hydrops allantois or hydrops amnion is an accumulation of excessive fluid in the allantoic or amniotic space, respectively.

<span class="mw-page-title-main">Nuchal cord</span> Medical condition

A nuchal cord is when the umbilical cord becomes wrapped around the fetus's neck. Symptoms present in the baby shortly after birth from a prior nuchal cord may include duskiness of face, facial petechia, and bleeding in the whites of the eye. Complications can include meconium, respiratory distress, anemia, and stillbirth. Multiple wraps are associated with greater risk.

<span class="mw-page-title-main">Placenta accreta spectrum</span> Medical condition

Placenta accreta occurs when all or part of the placenta attaches abnormally to the myometrium. Three grades of abnormal placental attachment are defined according to the depth of attachment and invasion into the muscular layers of the uterus:

  1. Accreta – chorionic villi attached to the myometrium, rather than being restricted within the decidua basalis.
  2. Increta – chorionic villi invaded into the myometrium.
  3. Percreta – chorionic villi invaded through the perimetrium.

In ABO hemolytic disease of the newborn maternal IgG antibodies with specificity for the ABO blood group system pass through the placenta to the fetal circulation where they can cause hemolysis of fetal red blood cells which can lead to fetal anemia and HDN. In contrast to Rh disease, about half of the cases of ABO HDN occur in a firstborn baby and ABO HDN does not become more severe after further pregnancies.

Hemolytic disease of the newborn (anti-Kell1) is the second most common cause of severe hemolytic disease of the newborn (HDN) after Rh disease. Anti-Kell1 is becoming relatively more important as prevention of Rh disease is also becoming more effective.

Hemolytic disease of the newborn (anti-Rhc) can range from a mild to a severe disease. It is the third most common cause of severe HDN. Rh disease is the most common and hemolytic disease of the newborn (anti-Kell) is the second most common cause of severe HDN. It occurs more commonly in women who are Rh D negative.

Placental insufficiency or utero-placental insufficiency is the failure of the placenta to deliver sufficient nutrients to the fetus during pregnancy, and is often a result of insufficient blood flow to the placenta. The term is also sometimes used to designate late decelerations of fetal heart rate as measured by cardiotocography or an NST, even if there is no other evidence of reduced blood flow to the placenta, normal uterine blood flow rate being 600mL/min.

<span class="mw-page-title-main">Kypros Nicolaides</span> Greek-Cypriot fetal medicine specialist

Kyprianos "Kypros" Nicolaides is a Greek Cypriot physician of British citizenship, Professor of Fetal Medicine at King's College Hospital, London. He is one of the pioneers of fetal medicine and his discoveries have revolutionised the field. He was elected to the US National Academy of Medicine in 2020 for 'improving the care of pregnant women worldwide with pioneering rigorous and creative approaches, and making seminal contributions to prenatal diagnosis and every major obstetrical disorder'. This is considered to be one of the highest honours in the fields of health and medicine and recognises individuals who have demonstrated outstanding professional achievement and commitment to service.

Neonatal alloimmune thrombocytopenia is a disease that affects babies in which the platelet count is decreased because the mother's immune system attacks her fetus' or newborn's platelets. A low platelet count increases the risk of bleeding in the fetus and newborn. If the bleeding occurs in the brain, there may be long-term effects.

Mirror syndrome, triple edema or Ballantyne syndrome is a rare disorder affecting pregnant women. It describes the unusual association of fetal and placental hydrops with maternal preeclampsia.

Hemolytic disease of the newborn (anti-RhE) is caused by the anti-RhE antibody of the Rh blood group system. The anti-RhE antibody can be naturally occurring, or arise following immune sensitization after a blood transfusion or pregnancy.

<span class="mw-page-title-main">Percutaneous umbilical cord blood sampling</span>

Percutaneous umbilical cord blood sampling (PUBS), also called cordocentesis, fetal blood sampling, or umbilical vein sampling is a diagnostic genetic test that examines blood from the fetal umbilical cord to detect fetal abnormalities. Fetal and maternal blood supply are typically connected in utero with one vein and two arteries to the fetus. The umbilical vein is responsible for delivering oxygen rich blood to the fetus from the mother; the umbilical arteries are responsible for removing oxygen poor blood from the fetus. This allows for the fetus’ tissues to properly perfuse. PUBS provides a means of rapid chromosome analysis and is useful when information cannot be obtained through amniocentesis, chorionic villus sampling, or ultrasound ; this test carries a significant risk of complication and is typically reserved for pregnancies determined to be at high risk for genetic defect. It has been used with mothers with immune thrombocytopenic purpura.

<span class="mw-page-title-main">Velamentous cord insertion</span> Velamentous placenta

Velamentous cord insertion is a complication of pregnancy where the umbilical cord is inserted in the fetal membranes. It is a major cause of antepartum hemorrhage that leads to loss of fetal blood and associated with high perinatal mortality. In normal pregnancies, the umbilical cord inserts into the middle of the placental mass and is completely encased by the amniotic sac. The vessels are hence normally protected by Wharton's jelly, which prevents rupture during pregnancy and labor. In velamentous cord insertion, the vessels of the umbilical cord are improperly inserted in the chorioamniotic membrane, and hence the vessels traverse between the amnion and the chorion towards the placenta. Without Wharton's jelly protecting the vessels, the exposed vessels are susceptible to compression and rupture.

<span class="mw-page-title-main">Monoamniotic twins</span> Identical twins sharing the same amniotic sac in the womb

Monoamniotic twins are identical or semi-identical twins that share the same amniotic sac within their mother's uterus. Monoamniotic twins are always monochorionic and are usually termed Monoamniotic-Monochorionic twins. They share the placenta, but have two separate umbilical cords. Monoamniotic twins develop when an embryo does not split until after formation of the amniotic sac, at about 9–13 days after fertilization. Monoamniotic triplets or other monoamniotic multiples are possible, but extremely rare. Other obscure possibilities include multiples sets where monoamniotic twins are part of a larger gestation such as triplets, quadruplets, or more.

<span class="mw-page-title-main">Monochorionic twins</span> Identical twins that share the same placenta

Monochorionic twins are monozygotic (identical) twins that share the same placenta. If the placenta is shared by more than two twins, these are monochorionic multiples. Monochorionic twins occur in 0.3% of all pregnancies. Seventy-five percent of monozygotic twin pregnancies are monochorionic; the remaining 25% are dichorionic diamniotic. If the placenta divides, this takes place before the third day after fertilization.

An Intrauterine transfusion (IUT) is a procedure that provides blood to a fetus, most commonly through the umbilical cord. It is used in cases of severe fetal anemia, such as when fetal red blood cells are being destroyed by maternal antibodies. IUTs are performed by perinatologists at hospitals or specialized centers.

Beryl Rice Benacerraf was an American radiologist and professor of obstetrics, gynecology and reproductive biology and radiology at Harvard Medical School. She was a pioneer in the use of prenatal ultrasound to diagnose fetal abnormalities, including Down syndrome. In 2021, she was recognized as a "Giant in Obstetrics and Gynecology" by the American Journal of Obstetrics & Gynecology.

References

  1. 1 2 Lopriore, E.; Middeldorp, J.M.; Oepkes, D.; Kanhai, H.H.; Walther, F.J.; Vandenbussche, F.P.H.A. (2007). "Twin Anemia–Polycythemia Sequence in Two Monochorionic Twin Pairs Without Oligo-Polyhydramnios Sequence". Placenta. 28 (1). Elsevier BV: 47–51. doi:10.1016/j.placenta.2006.01.010. ISSN   0143-4004. PMID   16516289.
  2. Tollenaar, L. S. A.; Lopriore, Enrico (2021). "Twin Anemia Polycythemia Sequence". Twin and Higher-order Pregnancies. Cham: Springer International Publishing. pp. 247–262. doi:10.1007/978-3-030-47652-6_16. ISBN   978-3-030-47651-9. S2CID   244850658.
  3. Tollenaar, Lisanne S.A.; Lopriore, Enrico; Oepkes, Dick; Haak, Monique C.; Klumper, Frans J.C.M.; Middeldorp, Johanna M.; Klink, Jeanine M.M. Van; Slaghekke, Femke (September 10, 2020). "Twin Anemia Polycythemia Sequence: Knowledge and Insights After 15 Years of Research". Maternal-Fetal Medicine. 3 (1). Ovid Technologies (Wolters Kluwer Health): 33–41. doi:10.1097/fm9.0000000000000065. hdl: 1887/3270935 . ISSN   2641-5895.
  4. 1 2 Tollenaar, Lisanne S.A.; Lopriore, Enrico; Faiola, Stefano; Lanna, Mariano; Stirnemann, Julien; Ville, Yves; Lewi, Liesbeth; Devlieger, Roland; Weingertner, Anne Sophie; Favre, Romain; Hobson, Sebastian R.; Ryan, Greg; Rodo, Carlota; Arévalo, Silvia; Klaritsch, Philipp; Greimel, Patrick; Hecher, Kurt; de Sousa, Manuela Tavares; Khalil, Asma; Thilaganathan, Basky; Bergh, Eric P.; Papanna, Ramesha; Gardener, Glenn J.; Carlin, Andrew; Bevilacqua, Elisa; Sakalo, Victorya A.; Kostyukov, Kirill V.; Bahtiyar, Mert O.; Wilpers, Abigail; Kilby, Mark D.; Tiblad, Eleonor; Oepkes, Dick; Middeldorp, Johanna M.; Haak, Monique C.; Klumper, Frans J.C.M.; Akkermans, Joost; Slaghekke, Femke (June 5, 2020). "Post-Laser Twin Anemia Polycythemia Sequence: Diagnosis, Management, and Outcome in an International Cohort of 164 Cases". Journal of Clinical Medicine. 9 (6). MDPI AG: 1759. doi: 10.3390/jcm9061759 . ISSN   2077-0383. PMC   7355738 . PMID   32517071.
  5. 1 2 Tollenaar, Lisanne S.A.; Slaghekke, Femke; Lewi, Liesbeth; Colmant, Claire; Lanna, Mariano; Weingertner, Anne Sophie; Ryan, Greg; Arévalo, Silvia; Klaritsch, Philipp; Tavares de Sousa, Manuela; Khalil, Asma; Papanna, Ramesha; Gardener, Glenn J.; Bevilacqua, Elisa; Kostyukov, Kirill V.; Bahtiyar, Mert O.; Kilby, Mark D.; Tiblad, Eleonor; Oepkes, Dick; Lopriore, Enrico (2021). "Spontaneous twin anemia polycythemia sequence: diagnosis, management, and outcome in an international cohort of 249 cases". American Journal of Obstetrics and Gynecology. 224 (2). Elsevier BV: 213.e1–213.e11. doi:10.1016/j.ajog.2020.07.041. hdl: 1887/3270933 . ISSN   0002-9378. PMID   32730900.
  6. 1 2 3 4 5 6 7 Slaghekke, F.; Kist, W.J.; Oepkes, D.; Pasman, S.A.; Middeldorp, J.M.; Klumper, F.J.; Walther, F.J.; Vandenbussche, F.P.H.A.; Lopriore, E. (2010). "Twin Anemia-Polycythemia Sequence: Diagnostic Criteria, Classification, Perinatal Management and Outcome". Fetal Diagnosis and Therapy. 27 (4). S. Karger AG: 181–190. doi:10.1159/000304512. ISSN   1015-3837. PMID   20339296.
  7. Baschat, Ahmet A.; Miller, Jena L. (2022). "Pathophysiology, diagnosis, and management of twin anemia polycythemia sequence in monochorionic multiple gestations". Best Practice & Research Clinical Obstetrics & Gynaecology. 84. Elsevier BV: 115–126. doi:10.1016/j.bpobgyn.2022.03.012. ISSN   1521-6934. PMID   35450772. S2CID   260972128.
  8. Herway, C.; Johnson, A.; Moise, K.; Moise, K. J. (2009). "Fetal intraperitoneal transfusion for iatrogenic twin anemia–polycythemia sequence after laser therapy". Ultrasound in Obstetrics & Gynecology. 33 (5): 592–594. doi:10.1002/uog.6334. ISSN   0960-7692. PMID   19402103.
  9. Nassr, Ahmed A.; Popek, Edwina J.; Espinoza, Jimmy; Sanz Cortes, Magdalena; Belfort, Michael A.; Shamshirsaz, Alireza A. (2021). "Twin anemia polycythemia sequence: Successful laser photocoagulation treatment and placental histopathological findings". Taiwanese Journal of Obstetrics and Gynecology. 60 (5). Elsevier BV: 916–919. doi: 10.1016/j.tjog.2021.07.024 . ISSN   1028-4559. PMID   34507674.
  10. Habli, Mounira; Bombrys, Annette; Lewis, David; Lim, Foong-Yen; Polzin, William; Maxwell, Rose; Crombleholme, Timothy (2009). "Incidence of complications in twin-twin transfusion syndrome after selective fetoscopic laser photocoagulation: a single-center experience". American Journal of Obstetrics and Gynecology. 201 (4). Elsevier BV: 417.e1–417.e7. doi:10.1016/j.ajog.2009.07.046. ISSN   0002-9378. PMID   19788973.
  11. Robyr, Romaine; Lewi, Liesbeth; Salomon, Laurent J.; Yamamoto, Masami; Bernard, Jean-Pierre; Deprest, Jan; Ville, Yves (2006). "Prevalence and management of late fetal complications following successful selective laser coagulation of chorionic plate anastomoses in twin-to-twin transfusion syndrome". American Journal of Obstetrics and Gynecology. 194 (3). Elsevier BV: 796–803. doi:10.1016/j.ajog.2005.08.069. ISSN   0002-9378. PMID   16522415.

Further reading